Clinical trial
Open-label Follow-up Trial of Fixed Dose Combination of Telmisartan +…
NCT00267943 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00267943 |
|---|---|
| Title | Open-label Follow-up Trial of Fixed Dose Combination of Telmisartan + Hydrochlorothiazide in Hypertensive Patients |
| Official title | An Open-label Follow-up Trial of the Efficacy and Safety of Chronic Administration of the Fixed Dose Combination of Telmisartan 80 mg + Hydrochlorothiazide 25 mg Tablets Alone or in Combination With Other Antihypertensive Medications in Patients With Hypertension. |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | telmisartan 80 mg + hydrochlorothiazide 25 mg |
| Enrollment | 639 |
| Start date | Jan 1, 2006 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Dec 22, 2005 |
| Last update posted | Nov 13, 2013 |
| Countries | Denmark, Finland, France, Germany, Hong Kong, Ireland, Italy, Malaysia, Netherlands, Norway, South Africa, South Korea and 4 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: